GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1 percent were SLN-positive.

The European Medicines Agency's committee has recommended approval of French drugmaker Sanofi's first-of-its-kind drug that delays onset of the insulin-dependent stage 3 of type 1 diabetes, it said on ...

A gene expression-based test identifies patients with primary cutaneous melanoma at a lower or higher risk for sentinel lymph ...

Millions of Americans with celiac disease or gluten sensitivity understand that even trace gluten can cause serious problems.

With numerous editions of Productronica behind it, EIIT — a Controlar company — will present its renewed series of in-line ...

Despite the president’s claims, crime in D.C. is down over the last two years. At an extraordinary news conference on Monday, President Donald Trump revealed plans to take over the Washington, D.C.

Some brands of common household items — think protein powder, cinnamon and cassava — have concerning amounts of lead, recent ...

Microbix Biosystms ( ($TSE:MBX) ) has shared an update. Microbix Biosystems Inc. has partnered with SEKISUI Diagnostics to support the U.S.

NSL Analytical Services, Inc., based in Cleveland, Ohio, has shared a case study by Dr Ross Cunningham, Director of Science ...